-
公开(公告)号：US20230192900A1
公开(公告)日：2023-06-22
申请号：US17929028
申请日：2020-02-13
申请人： UCB BIOPHARMA SRL
IPC分类号： C07K16/46
CPC分类号： C07K16/468 , C07K2317/31 , C07K2317/24 , C07K2317/94 , C07K2317/565
摘要： The present invention relates to multispecific antibodies against a novel targets' combination of HVEM and CD9, and their use in the treatment of cancer and infectious diseases.
-
公开(公告)号：US20230151109A1
公开(公告)日：2023-05-18
申请号：US17929031
申请日：2020-02-13
申请人： UCB BIOPHARMA SRL
CPC分类号： C07K16/2896 , C07K16/2878 , A61P35/00 , C07K2317/31 , C07K2317/55 , C07K2317/622 , C07K2317/75
摘要： The present invention relates to multispecific antibodies against a novel targets' combination of CD9 and another antigen, and their use in the treatment of cancer and infectious diseases.
-
公开(公告)号：US20230096030A1
公开(公告)日：2023-03-30
申请号：US17929029
申请日：2020-02-13
申请人： UCB BIOPHARMA SRL
IPC分类号： C07K16/28
摘要： The present invention relates to multispecific antibodies against a novel targets' combination of CD7 and CD9, and their use in the treatment of cancer and infectious diseases.
-
公开(公告)号：US20230151108A1
公开(公告)日：2023-05-18
申请号：US17929026
申请日：2020-02-13
申请人： UCB BIOPHARMA SRL
IPC分类号： C07K16/28 , C07K14/765 , A61P35/00
CPC分类号： C07K16/2896 , C07K16/2878 , C07K14/765 , A61P35/00 , A61K2039/505
摘要： The present invention relates to multispecific antibodies against a novel targets' combination of CD137 and CD9, and their use in the treatment of cancer and infectious diseases.
-
公开(公告)号：US20230125234A1
公开(公告)日：2023-04-27
申请号：US17929032
申请日：2020-02-13
申请人： UCB BIOPHARMA SRL
摘要： The present disclosure relates to a bispecific anti CD44/anti CTLA4 antibody. The antibody construct has defined CDRs and variable chains sequences. The bispecific antibodies has improved activity on CDS and CD4 T cells compared to known antibodies.
-
-
-
-
搜索结果
5 条记录 (耗时 0.013 秒)
